SARS-CoV-2 Vaccine (Vero Cell), Inactivated
CNBG2021001
Phase 3 mab completed
Quick answer
SARS-CoV-2 Vaccine (Vero Cell), Inactivated for COVID-19 Pneumonia is a Phase 3 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- COVID-19 Pneumonia
- Phase
- Phase 3
- Modality
- mab
- Status
- completed